Arctium Capital is a family office and investment company established to manage investments and foundations of Čičak family.


Arctium Capital is dedicated to follow ESG principles in their investment decisions to build an ethical and sustaniable organizations. Arctium Capital aims to create a meaningful impact on social and environmental issues in our communities.


Main activities of Arctium Capital are:

Equity investments in early and late-stage start-up companies

Growth capital investments in minority and majority equity stakes in small to medium size enterprises

Our targeted sectors are digital health, digital therapeutics, pharmaceuticals and biotechnology.


Gordana Gregurić Čičak
Gordana Gregurić Čičak

Gordana Gregurić Čičak is a Co-Founder and Chief Executive Officer of Arctium Capital.

Gordana has a strong track record in the executive management within CRO industry. She founded Optimapharm CRO in 2006 and performed CEO function at Optimapharm for 14 years, growing the company from SEE regional niche player to a full-service, pan-European CRO with offices and operational presence in more than 40 countries in Europe and Israel. Global PE firm, The Rohatyn Group, acquired majority stake in Optimapharm in May 2020, when Gordana moved to the position of COO at Optimapharm, which position she held until November 2022.

In the position of CEO and respectively COO at Optimapharm, during period of 5 years, Gordana was involved with 8 acquistions that Optimapharm executed across Europe and she was leading related integration processes.

Prior to that, during period from 1998 to 2006, Gordana performed senior management and regional management positions at global and international CRO companies (Ingenix Pharmaceutial Services/ i3 Research, Ergomed, ClinPharm, SAR Monitoring Services).

Gordana graduated from the Medical School, the University of Zagreb in 1995. In 2001, completed postgraduate studies in Clinical Pharmacology with Toxicology. Attended the Chief Executive MBA program at Cotrugli Business School.

Igor Čičak
Igor Čičak

Igor Čičak is a Co-Founder of Arctium Capital.

Igor has a track record of 25+ years in executive management and private equity in CEE region.

Igor is founder and CEO at Provectus Capital Partners (PCP). PCP is an independent investment firm, with a focus on South – Eastern Europe. PCP has established the largest private equity fund with operations in Adria region. PCP applies partnership approach and typically invests majority stakes in companies in growing sectors, with market leading position and solid industry consolidation potential.

Prior to founding PCP in 2019, Igor was CEO of Provectus Capital, a specialized investment and M&A firm that was active in SEE region.

Igor is founder of Optimapharm and he has served as Chairman of the Supervisory Board from 2011 until 2020. Global PE firm The Rohatyn Group acquired majority stake in Optimapharm in early 2020.

During period 2006-2011, Igor was CEO of regional bank in Croatia.

Prior to that Igor performed senior and top executive positions with local and international banks (HVB/Bank Austria) and large corporates.

Igor graduated from Faculty of Economics and Business in Zagreb, completed GMP program in Vienna, and finished Senior Executive Program at London Business School.


Ivana Gorana Kovačića 17, 10000 Zagreb, Croatia